Cspc Innovation Pharmaceutical Rises On Upbeat First: half profit outlook
BUZZ-CSPC Innovation Pharmaceutical rises on upbeat first-half profit outlook ** Shares of CSPC Innovation Pharmaceutical 300765.SZ rise as much as 8.2% to 39.4 yuan, their biggest intraday pct gain since July 20
** Shares of CSPC Pharmaceutical-backed 1093.HK subsidiary on course to snap five consecutive sessions of decline, if current trend holds
** The China-based R&D and functional ingredients producer expects its first-half net profit to come in at 1.18 billion yuan-1.36 billion yuan ($174.36 million-$200.96 million), a sharp turnaround from a 2.74 million yuan loss a year earlier
** YTD, CSPC Innovation stock up 7.47%, while benchmark CSI300 Index .CSI300 down 0.7%
($1 = 6.7675 Chinese yuan)
(Reporting by Donny Kwok)
Recent news on CSPC PHARMACEUTICAL
See all newsBrief: CSPC Pharmaceutical Posts CSPC Innovation Pharmaceutical 9M Net Profit Attributable RMB 1.21 Billion
Brief: CSPC Pharmaceutical Publishes Updated Phase III OS Results For Anbenitamab In Her2-Positive Advanced Gastric Cancer
Brief: CSPC Pharmaceutical Says Batoclimab Injection (Enlida) Obtains Drug Registration Certificate From NMPA
Brief: CSPC Pharmaceutical Initiates Phase III Trial Of SYS6043 For Triple-Negative Breast Cancer In China
Factbox: Pharma sector doubles down on AI to slash costs, timelines